United States

People: Sun Pharmaceutical Industries Ltd (SUN.BO)

SUN.BO on Bombay Stock Exchange

21 Sep 2017
Change (% chg)

-- (--)
Prev Close
Day's High
Day's Low
Avg. Vol
52-wk High
52-wk Low

Shanghvi, Dilip 

Mr. Dilip Shantilal Shanghvi serves as Managing Director, Executive Director of Sun Pharmaceutical Industries Limited. He resigned as Executive Chairman of the Board of the Company, effective May 28, 2012. He is a graduate from Calcutta University and has launched Sun Pharma in 1982 and carries industrial experience in the Pharmaceutical industry and at present he is the Chairman and Managing Director of the Company. His other directorships includes: Caraco Pharmaceutical Laboratories Ltd., Detroit, USA, Sun Speciality Chemicals Pvt. Ltd., Sun Resins & Polymers Pvt. Ltd., Sun Fastfin Services Pvt. Ltd., Sun Petrochemicals Private Limited, SPARC Bio-Research Private Limited, Sun Pharma Global Inc., British Virgin Island, Sun Pharma De Mexico SA DE CV, SPIL De Mexico SA DE CV and Shantilal Shanghvi Foundation.

Basic Compensation

Total Annual Compensation, INR 17,661,400
Restricted Stock Awards, INR --
Long-Term Incentive Plans, INR --
All Other, INR 2,717,370
Fiscal Year Total, INR 20,378,800

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --